Accessibility Menu
 
Nyrada logo

Nyrada

(ASX) NYR

Current Price$0.60
Market Cap$145.96M
Since IPO (2020)+155%
5 Year+98%
1 Year+450%
1 Month+8%

Nyrada Financials at a Glance

Market Cap

$145.96M

Revenue (TTM)

$3.25M

Net Income (TTM)

$9.56M

EPS (TTM)

$-0.02

P/E Ratio

-24.10

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.60

Volume

22,512

Open

$0.60

Previous Close

$0.60

Daily Range

$0.60 - $0.61

52-Week Range

$0.10 - $1.44

NYR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nyrada

Industry

Pharmaceuticals

CEO

James Bonnar

Headquarters

Gordon, NSW 2072, AU

NYR Financials

Key Financial Metrics (TTM)

Gross Margin

-61%

Operating Margin

-6%

Net Income Margin

-3%

Return on Equity

-71%

Return on Capital

-90%

Return on Assets

-54%

Earnings Yield

-4.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$145.96M

Shares Outstanding

243.26M

Volume

22.51K

Short Interest

0.00%

Avg. Volume

641.79K

Financials (TTM)

Gross Profit

$1.98M

Operating Income

$9.20M

EBITDA

$5.00M

Operating Cash Flow

$5.05M

Capital Expenditure

$0.00

Free Cash Flow

$5.05M

Cash & ST Invst.

$2.93M

Total Debt

$0.00

Nyrada Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$1.46K

-100.1%

Gross Margin

0.00%

N/A

Market Cap

$145.96M

N/A

Market Cap/Employee

$145.96M

N/A

Employees

1

N/A

Net Income

$3.18M

-2451.6%

EBITDA

$4.01M

-79.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$7.12M

+53.3%

Accounts Receivable

$3.02M

+1256.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-53.59%

N/A

Return on Invested Capital

-89.80%

N/A

Free Cash Flow

$4.46M

-576.9%

Operating Cash Flow

$4.46M

-576.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EMV.AXEMVision Medical Devices Ltd
$1.55-1.58%
RCE.AXRecce Pharmaceuticals Ltd
$0.48+5.49%
ACW.AXActinogen Medical Limited
$0.04+0.00%
AVH.AXAVITA Medical, Inc.
$1.30+8.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$61.70+0.05%
NOKNokia
$9.54+0.01%
NVDANvidia
$183.89+0.01%
NIONio
$6.08-0.05%

Questions About NYR

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.